Plasma protein binding of fentanyl
- 1 September 1981
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 33 (1) , 507-514
- https://doi.org/10.1111/j.2042-7158.1981.tb13849.x
Abstract
Whole plasma of 15 normal volunteers bound 79·16% ± 0·16 s.e. (n = 45) of fentanyl, at a concentration of 0·6 ng ml−1. Measurement was by equilibrium dialysis at 37°C, pH 7·4. The largest contribution to binding appears to be due to serum albumin, since 45·52% ± 0·40 s.e. (n = 3) of fentanyl was bound to a solution of purified albumin at a concentration of 46 g litre−1 in buffer. Physiological concentrations of isolated very low density, low density and high density lipoprotein fractions in buffer bound 18·39% ± 0·65 s.e.; 39·14% ± 0·42 and 21·18% ± 0·51 (n = 15) respectively. A significant correlation was found between percent binding and serum albumin concentration (r = 0·745, P = 0·0022) and oestrogen and progestagen therapy (r = 0·766, P = 0·0014). There was no significant correlation with fasting serum cholesterol, triglyceride, age, sex or the concentration of total protein minus albumin. Binding to fibrinogen and α1-acid glycoprotein did not occur. Binding increased with increasing pH, temperature and ionic strength of the buffer. The results were compatible with hydrophobic bond formation between fentanyl and proteins. Fentanyl concentration did not affect the percent bound to whole plasma or the protein fractions over a range of 0·6 ng-10 mg ml−1. Dilution of plasma with buffer gave a linear relation of percent bound or free to log plasma dilution. The binding of fentanyl to pooled plasma of the normal subjects was not affected by a wide variety of anionic, cationic and uncharged drugs when these were tested at a concentration of 20 μg ml−1. At higher concentrations, aspirin, phenylbutazone and quinidine caused inhibition of fentanyl binding. A linear relation was found between percent bound and concentration of the inhibitory ligand. For aspirin, r = 0·873, P <0·01; for phenylbutazone, r = 0·81, P <0·05; and for quinidine, r = 0·982, P <0·01. Aspirin and phenylbutazone inhibited binding of fentanyl to albumin, while quinidine caused inhibition of binding to lipoproteins of all three densities, but not to albumin. Changes in the concentrations of the common ions of plasma (except H+), of free fatty acids and of creatinine did not affect fentanyl binding to whole plasma. 8 M urea reduced binding by 25% of the normal value.This publication has 32 references indexed in Scilit:
- The binding of chloramphenicol to albumin of normal and uremic seraBiochemical Pharmacology, 1978
- Binding of chlorpromazine and imipramine to red cells, albumin, lipoproteins and other blood componentsJournal of Pharmacy and Pharmacology, 1975
- INCREASING ACTIVITY OF SULFONAMIDES WITH DISPLACING AGENTS: A REVIEWAnnals of the New York Academy of Sciences, 1973
- Serum tryptophan level after carbohydrate ingestion: Selective decline in non-albumin-bound tryptophan coincident with reduction in serum free fatty acidsLife Sciences, 1973
- Effects of oestrogen and progestogen on serum levels of α2-macroglobulin, transferrin, albumin, and IgGJournal of Clinical Pathology, 1971
- Effect of physiological variations in free fatty acid concentration on the binding of thyroxine in the serum of euthyroid and thyrotoxic subjectsJournal of Clinical Investigation, 1969
- STUDIES ON THE FATE OF FENTANYLThe Keio Journal of Medicine, 1969
- The metabolism and excretion of the analgesic fentanyl (R 4263) by wistar ratsLife Sciences, 1968
- The Interaction of Human Serum Albumin with Long-chain Fatty Acid AnionsJournal of the American Chemical Society, 1958
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955